Perigon Wealth Management LLC Purchases Shares of 9,796 MetLife, Inc. $MET

Perigon Wealth Management LLC acquired a new position in MetLife, Inc. (NYSE:MET) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 9,796 shares of the financial services provider’s stock, valued at approximately $829,000.

Several other institutional investors also recently bought and sold shares of MET. Norges Bank bought a new stake in MetLife in the fourth quarter valued at approximately $639,986,000. Vanguard Group Inc. grew its holdings in shares of MetLife by 12.1% in the fourth quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock worth $5,727,518,000 after purchasing an additional 7,805,814 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of MetLife in the second quarter worth $293,287,000. Pzena Investment Management LLC increased its stake in shares of MetLife by 22.9% in the fourth quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock worth $938,071,000 after buying an additional 2,211,315 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its holdings in MetLife by 133.5% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 3,098,649 shares of the financial services provider’s stock valued at $219,136,000 after buying an additional 1,771,689 shares during the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

MetLife Stock Performance

NYSE:MET opened at $96.83 on Wednesday. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The firm’s fifty day simple moving average is $92.00 and its 200 day simple moving average is $81.86. The stock has a market cap of $62.31 billion, a P/E ratio of 18.55, a price-to-earnings-growth ratio of 0.75 and a beta of 0.78. MetLife, Inc. has a twelve month low of $67.33 and a twelve month high of $100.93.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, topping the consensus estimate of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business had revenue of $13.52 billion during the quarter, compared to analyst estimates of $19.67 billion. During the same period in the prior year, the business earned $2.02 EPS. The company’s revenue for the quarter was up 10.5% on a year-over-year basis. As a group, research analysts predict that MetLife, Inc. will post 9.7 EPS for the current year.

MetLife announced that its board has authorized a stock buyback plan on Wednesday, August 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to repurchase up to 4.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s board believes its stock is undervalued.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be paid a $0.5925 dividend. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, August 4th. MetLife’s dividend payout ratio is presently 45.40%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. TD Cowen increased their price target on shares of MetLife from $87.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. upped their price objective on shares of MetLife from $106.00 to $108.00 and gave the company an “overweight” rating in a research note on Tuesday, August 11th. Jefferies Financial Group increased their target price on shares of MetLife from $97.00 to $103.00 and gave the stock a “buy” rating in a report on Friday, July 10th. Mizuho raised their target price on MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Finally, Wall Street Zen downgraded MetLife from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.07.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.